Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02631733
Title Liposomal Irinotecan and Veliparib in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Recruitment Suspended
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

lung non-small cell carcinoma

stomach cancer

ovarian cancer

cervical cancer

neuroendocrine tumor

triple-receptor negative breast cancer

lung small cell carcinoma

Therapies

Irinotecan + Veliparib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore Maryland 21287 United States Details
National Institutes of Health Clinical Center Bethesda Maryland 20892 United States Details
NCI - Center for Cancer Research Bethesda Maryland 20892 United States Details
Mayo Clinic in Rochester Rochester Minnesota 55905 United States Details
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York New York 10032 United States Details
Cleveland Clinic Foundation Cleveland Ohio 44195 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field